We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Artificial intelligence tools continue to be a focal point among publicly traded digital health companies looking to improve ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 ...

Coverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...

Medicare Part D spending for 10 selected diabetes drugs totaled more than $35.8 billion in 2023, a 364% increase from 2019, according to a new data brief from the Department of Health and Human Servic ...

Opinion: It’s time we prioritize innovation and invest in solutions that truly address the root cause of this chronic and ...